Navigation Links
Applisonix Announces Breakthrough in Ultrasound Technology for Hair Removal - Average Hair Reduction of 38% Following Initial Treatment
Date:7/1/2008

REHOVOT, Israel, July 1 /PRNewswire-FirstCall/ -- Applisonix LTD (TASE: APLS), a developer of innovative ultrasound based solutions for the aesthetic market, announced today that the test conducted using its hair removal prototype achieved, following an initial treatment, average hair reduction of 38%, which positions its efficacy within the top professional long-term hair removal solutions.

Applisonix' co-CEOs, Mr. Alon Goren and Mr. Uri Amir, stated that the test results indicate that the technology developed by Applisonix can be safely and effectively implemented for men and women. Mr. Goren estimates that compared to commercially available long-term hair removal solutions, Applisonix' solutions are planned to be safer, less painful, more affordable, and applicable to all hair and skin tones, Mr. Amir added that the company intends to launch its first device, Selectif(TM), in the first quarter of 2009, as planned.

Applisonix conducted tests on men and women for a period of several months. The test results were examined by Prof. Kassuto (Milan, Italy), an external, independent, internationally recognized expert. Prof. Kassuto verified and evaluated the findings and concluded that the new technology's efficacy is similar to the efficacy of the top commercial light based systems, and without any side effects, and regardless of hair and skin color.

In addition, it appears from Prof. Kassuto's review, that following the initial treatment using the prototype and Applisonix' technology (IMPRESA(TM)), there was an average 38% hair reduction, compared to the controlled area, which was not treated. The treatment was given to 36 people, men and women, with different hair colors and skin tones, and the results were statistically significant.

These results reflect the new technology's capability of competing with expensive professional light-based systems. From studies published in this field, it seems that with most light based systems, one
'/>"/>

SOURCE Applisonix Ltd.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Silence Therapeutics Announces Board Changes
2. ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
3. Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
4. Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)
5. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
6. XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
7. CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer
8. Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis
9. Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery
10. CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
11. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...9 Landauer, Inc. (NYSE...ronmental radiation monitoring services, today ann...dance with its long-term strategic priorities. ,... Global Physics Solutions, Inc. (GPS) and Gammadat...nt and CEO of Landauer. "These acquisitions positi...
(Date:11/9/2009).../PRNewswire-Asia-FirstCall/ -- American Oriental,B...or "AOBO"), a pharmaceutical,company dedicated to ...ure and,commercialization of a broad range of pres...day announced that it plans to release third quart...2009, after the market closes. , The Comp...
(Date:11/9/2009)...ewswire/ -- Patent attorneys Cheryl Liljestrand, P...ill showcase Stipkala LLC at the Texas Life Scienc...eld at the Institute of Molecular Medicine in Hous...es a platform for cutting-edge companies to introd...ill feature keynote addresses and panel discussion...
Breaking Medicine Technology:Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 2Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 3Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 4Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 5Critical Information Network 28CiNet 28TM 29 29 Launches to Provide eLearning Solutions to Public Safety Healthcare and Industrial Operations Profes 49270 1Critical Information Network 28CiNet 28TM 29 29 Launches to Provide eLearning Solutions to Public Safety Healthcare and Industrial Operations Profes 49270 2Critical Information Network 28CiNet 28TM 29 29 Launches to Provide eLearning Solutions to Public Safety Healthcare and Industrial Operations Profes 49270 3Cancer Treatment Centers of America 28R 29 Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells 4608 1Cancer Treatment Centers of America 28R 29 Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells 4608 2Cancer Treatment Centers of America 28R 29 Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells 4608 3Cancer Treatment Centers of America 28R 29 Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells 4608 4Taking Aim at Relapse of Leukemia in Kids 49267 1Taking Aim at Relapse of Leukemia in Kids 49267 2
...ta ASA (OSE: ALGETA), the,Norwegian cancer therape...ind Bruland, of the Norwegian Radium Hospital, Osl... Discussion entitled,"Radium-223 in the treatment...(HRPC): Results from a randomized,placebo-control...linical Oncology,s annual meeting (1-5 June 2007, ...
...7- Results from various,clinical studies including...ed hepatocellular carcinoma, or primary liver canc...ted at the Annual,Meeting of the American Society ...une 1 - 5, 2007. , On this occasion a conference c...e 4, 2007. Starting at around 2:00 p.m. CEST,(12:0...
Other Medicine Technology:Algeta to Present Phase II Clinical Study Data for Alpharadin in,Prostate Cancer at ASCO 2
(Date:11/9/2009)... -- Sutter Health, a family of doctors, not-for-pr...ders, is donating $255,000 to food banks across No...ill share the quarter-million-dollar donation to h...ds of families across the north state. ,, Sut...nd supporting charitable programs and services. Th...
(Date:11/9/2009)... inhibit estrogen, , , MONDAY, Nov. 9 (...cancer and osteoporosis eliminated cervical cancer... also cleared precancerous growths in the cervix a...ce with precancerous lesions. , The breast canc...osis drug raloxifene were given to mice geneticall...
(Date:11/9/2009)...ons are age-related, researchers say , ,...ry doesn,t appear to speed the progression of age-... new study that challenges the belief that treatin... "Because both conditions are strongly age-related...rote Li Ming Dong, of Stony Brook University Schoo...
(Date:11/9/2009)...stCall/ - Hard To Treat Diseases (HTDS.PK) www.ht...S$41 billion international healthcare company, is ...er, Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.... begin a five-year, $1 billion China initiative wi...e its investment in its China R&D facility, an...
(Date:11/9/2009)...rk (NCCN) has posted a draft white paper for publi...erm comparative effectiveness clinical evaluations... the NCCN Comparative Therapeutic Index(TM) (CTI),...versus-benefit of different treatment options reco...n Oncology(TM). The paper will be posted for publi...
Breaking Medicine News(10 mins):Health News:Sutter Health Donates $255,000 to Help the Hungry This Holiday Season 2Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4
...f news for working couple in India. A study in the...r a year or more tended// to become disruptive in ...e. The finding held up regardless of the chil...te of Child Health and Human Development, recruite...
...rganization (WHO) has approved four new drugs manu... tuberculosis, agency reports say//. And one of th...sistant to standard treatment. The addition ... The medicines are the first TB products to be ad...
..., researchers are discovering that some foods and ...ntion of the modern// world’s deadliest killer- th...erican Chemical Society, a one-day symposium, more...ing cancer of the esophagus, colon — Using animal ...
...he University of California have found out that or... than the ones that are grown// under conventional...agazine Chemistry & Industry. UK environment secre...Amodio and Adel Kader, showed that organically gro...
...iversity of Wisconsin-Madison claim that they can ...eaving out healthy cells//. This is very similar t...ell from another. The new tumor targeting stra...ies and immune responses. "The killing agent we ch...
...Ministry of Thailand plans to set up 21 community ...to relieve the heavy workload of provincial// hosp...ing with patients. The project estimated to c...vongvirot has said that 13 centres will be built i...
Other Medicine News:Health News:Poor Behavior Is Linked to Time in Day Care 2Health News:Indian Pharma Authorized to Market New Anti-TB Drugs 2Health News:Emboldened Warriors-Cancer Fighting Foods 2Health News:Emboldened Warriors-Cancer Fighting Foods 3Health News:organic kiwifruits promote health 2Health News:Tumors Targeted Naturally 2Health News:Tumors Targeted Naturally 3Health News:Hospital Projects to Take the Weight Off Overcrowded Ones 2
...able laparoscopic 12 mm linear cutting stapler for...ium staples., ,The stapler places two triple, sta... the knife divides the tissue in between. The inst...e surgical procedure: it can be reloaded up to 7 t...
...g unit for reloadable rotating (360°) linear s...tion and anastomosis with titanium staples., ,The...nium staples and simultaneously the knife divides ...for multiple use during a single surgical procedur...
ENDO GIA ROTICULATOR™ (Single Use Loading Units (SULU's) with Titanium Staples)
... Thoracic Endoscopic Linear Cutter has application...urgical procedures for transection, resection, and...taple line buttressing materials such as bovine pe... for a total of eight firings. Different cartridge...
Medicine Products: